Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
Zoltán Szekanecz, Maya H Buch, Christina Charles‐Schoeman, James Galloway, George Karpouzas, Lars Erik Kristensen, Steven R. Ytterberg, Attila Hamar, Roy Fleischmann
Topics & Concepts
TofacitinibMedicineRheumatoid arthritisJanus kinaseJanus kinase inhibitorInternal medicineClinical trialAdverse effectIntensive care medicineCytokineRheumatoid Arthritis Research and TherapiesLymphoma Diagnosis and TreatmentCytokine Signaling Pathways and Interactions